The bone graft uses proprietary nanocrystalline hydroxyapatite and collagen-based biopolymer to promote bone growth in the posterolateral spine. The implantation occurred in Europe and opened the doors for global distribution.
More Articles on Spine Devices:
AxioMed Spine Receives CE Mark for cervical Disc
TransCorp Spine Names Christopher Welch President & CEO
6 New Spine Device Company Financial Reports
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.